Plastic Surgery

How Long After Stopping a GLP-1 Before Elective Plastic Surgery?

Published October 15, 2026 · Haute MD Editorial Team

There is no single FDA-labeled number of days or weeks that every patient must stop a GLP-1 receptor agonist (for example semaglutide products such as Ozempic or Wegovy) before elective plastic surgery. Current FDA prescribing information for Ozempic and Wegovy states that these medicines delay gastric emptying; that rare postmarketing cases of pulmonary aspiration have been reported in patients on GLP-1 receptor agonists who had residual stomach contents during elective procedures requiring general anesthesia or deep sedation, despite reported adherence to preoperative fasting recommendations; and that available data are insufficient to inform recommendations on whether changing fasting rules or temporarily stopping the drug reduces that risk. The labels tell patients to inform their healthcare providers before any planned surgery or procedure. Whether your surgeon and anesthesiologist ask you to pause, or to continue with extra precautions, is an individualized clinical decision. This is general information, not medical advice.

At a glance

FDA labels (Ozempic and Wegovy): the drugs delay gastric emptying; rare aspiration reports; no specific hold period is given; tell providers before planned surgeries. ASA multi-society guidance (October 2024 press release): most patients should continue GLP-1 drugs before elective surgery; patients at highest risk for significant GI side effects may follow a 24-hour liquid diet, with an adjusted anesthesia plan; elective surgery should be deferred during the dose-escalation phase or while significant GI symptoms are present. ASPS news articles: two articles quote individual member surgeons, one saying many anesthesiologists want weight-loss medicines stopped at least two to three weeks before general anesthesia, another saying injectable GLP-1s need to be stopped approximately a week before surgery. Those are individual comments, not a formal ASPS numeric standard. What to do: tell your surgeon and your anesthesiologist early about every GLP-1 (brand, dose, date of last dose), follow their written plan, and if you take the drug for diabetes, involve the prescribing clinician before any hold.

Why GLP-1 timing matters for elective surgery

GLP-1 receptor agonists slow how quickly the stomach empties. Under general anesthesia or deep sedation, food or liquid still in the stomach can be regurgitated and inhaled (aspiration), which can cause serious lung injury. That is why labels, anesthesiology groups, and plastic surgeons all treat GLP-1 use as something to disclose before surgery, even when they differ on whether the default is to hold the drug or continue it with precautions.

What the FDA labels say, and what they do not say

The Ozempic and Wegovy prescribing information (section 5.10, Pulmonary Aspiration During General Anesthesia or Deep Sedation) says the drug delays gastric emptying; that there have been rare postmarketing reports of pulmonary aspiration in patients receiving GLP-1 receptor agonists who underwent elective surgeries or procedures requiring general anesthesia or deep sedation and had residual gastric contents despite reported adherence to preoperative fasting recommendations; and that available data are insufficient to inform recommendations to mitigate the risk, including whether modifying preoperative fasting recommendations or temporarily discontinuing the drug could reduce retained gastric contents. Patients are instructed to inform healthcare providers before any planned surgery or procedure. The labels do not give a number of days or weeks to stop.

What multi-society perioperative guidance says (2024)

On October 29, 2024, the American Society of Anesthesiologists (ASA) announced multi-society clinical practice guidance developed with the American Gastroenterological Association, the American Society for Metabolic and Bariatric Surgery, the International Society of Perioperative Care of Patients with Obesity, and the Society of American Gastrointestinal and Endoscopic Surgeons. Per the ASA release: most patients should continue GLP-1 drugs before elective surgery, and patients at low risk for delayed stomach emptying can continue them. The care team should weigh patient-specific risk factors. For patients at highest risk, the guidance describes a liquid-only diet for 24 hours before surgery, adjusting the anesthesia plan, and point-of-care ultrasound of the stomach right before the procedure. Patients in the escalation phase, which the release says typically lasts four to eight weeks depending on the drug and the reason it is prescribed, are more likely to have delayed emptying, and elective surgery should be deferred until escalation has passed and GI side effects have dissipated. Patients with GI symptoms such as nausea, vomiting, abdominal pain or constipation should wait until symptoms resolve. The guidance also says teams should weigh the risk of pausing the drug, including effects on blood sugar in people with diabetes. That is risk-based continuation, not a universal multi-week stop, and your surgical team may still choose a different plan based on your history and the procedure.

Why you may still hear "stop for weeks"

ASPS consumer news articles discuss the same aspiration concern and quote individual member surgeons about their practices: stopping weight-loss medicines at least two to three weeks before general anesthesia in one article, and approximately a week before surgery for injectable GLP-1s in a diabetes-focused piece. Those describe what some practices do. They are not the FDA label language or the multi-society guidance. Ask your board-certified plastic surgeon and anesthesiologist which protocol they use and why.

Questions to ask before elective plastic surgery

Have you told both the surgeon and the anesthesiologist the exact GLP-1 product, dose, and date of your last dose? Is the plan to continue, hold, or defer, and for how long, in writing? If you take the drug for diabetes, who manages your blood sugar while it is held? Are you in a dose-escalation phase or having GI symptoms now? Will you be asked to follow a liquid diet day or other fasting change beyond standard instructions? Does the plan differ for local anesthesia versus general anesthesia or deep sedation? When is it appropriate to restart the drug after surgery? For body contouring after major GLP-1 weight loss, see Body Contouring After Ozempic & Mounjaro, a member editorial on a different topic than perioperative timing.

Find a plastic surgeon

Start with Find a Doctor and the plastic surgery listings. Dr. William Bruno is a board-certified plastic surgeon in West Hollywood, California, and owner and lead surgeon of William Bruno Plastic Surgery; his profile lists cosmetic and reconstructive procedures of the body, breasts, and buttocks. Dr. Oliver Chang is a double board-certified plastic surgeon in Miami, Florida (American Board of Plastic Surgery and American Board of Surgery); his profile lists aesthetic surgery of the face and body, including body contouring. Neither profile discusses GLP-1 timing. Ask any surgeon how their team manages GLP-1 medicines around elective procedures.

Sources

FDA, Ozempic (semaglutide) prescribing information, section 5.10 (https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/209637s038lbl.pdf). FDA, Wegovy (semaglutide) prescribing information, section 5.10 (https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/218316s005lbl.pdf). American Society of Anesthesiologists, "Most Patients Can Continue Diabetes, Weight Loss GLP-1 Drugs Before Surgery, Those at Highest Risk for GI Problems Should Follow Liquid Diet Before Procedure," October 29, 2024 (https://www.asahq.org/about-asa/newsroom/news-releases/2024/10/new-multi-society-glp-1-guidance). ASPS, "Understanding how medications interact with anesthesia and when to stop before plastic surgery" (https://www.plasticsurgery.org/news/articles/understanding-how-medications-interact-with-anesthesia-and-when-to-stop-before-plastic-surgery). ASPS, "Important considerations for diabetics seeking plastic surgery" (https://www.plasticsurgery.org/news/articles/important-considerations-for-diabetics-seeking-plastic-surgery). Source label PDFs and the ASA release were checked on October 15, 2026. This information is general education, not medical advice, and does not create a doctor–patient relationship; medication holds and surgical timing must be set by your treating clinicians.

Frequently Asked Questions

How long after stopping Ozempic can I have plastic surgery?

FDA labels for Ozempic and Wegovy do not set a specific hold period. The 2024 multi-society guidance summarized by the ASA says most patients should continue GLP-1 drugs with risk-based precautions, while some plastic-surgery practices use holds of a week or more. Follow your surgeon and anesthesiologist's written plan.

Why do GLP-1 drugs matter for anesthesia?

They delay gastric emptying. Residual stomach contents under general anesthesia or deep sedation raise the risk of aspiration. The labels describe rare postmarketing aspiration reports even in patients who reported following fasting instructions.

Should I stop my GLP-1 on my own before a consult?

Do not change a prescribed diabetes or weight-management medicine without clinician guidance. Bring your medication list to the consult and ask for a coordinated plan.

What if I am still increasing my dose?

The ASA's release says patients in the escalation phase are more likely to have delayed stomach emptying and that elective surgery should be deferred until escalation has passed and GI side effects have dissipated.

Is this the same as a body-contouring-after-Ozempic guide?

No. Timing before anesthesia is a safety and protocol question. Contouring after major weight loss is a separate surgical-planning topic; see the related member editorial on body contouring after GLP-1 weight loss.

Featured Haute MD Physicians

Dr. William Bruno · Dr. Oliver Chang

Browse Haute MD physicians

Get Help Now

Speak with a Haute MD Plastic Surgery physician

Are you a Plastic Surgery physician?

Join Haute MD Network and have your profile featured alongside these answers.

Apply for the Network

Related Guides

Guide · PLASTIC SURGERY

What Is a Facelift?

A facelift is a surgical procedure that repositions facial tissues and skin to reduce sagging and restore a more youthful appearance. Learn about facelift techniques and results.

Read Guide